Skip to main content
logo
Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.8420
-0.0080 (-0.94%)
May 14, 2026, 5:35 PM CET

Transgene Revenue

In the year 2025, Transgene had annual revenue of 7.21M EUR with 13.49% growth. Transgene had revenue of 2.63M in the half year ending December 31, 2025, a decrease of -16.13%.

Revenue
7.21M
Revenue Growth
+13.49%
P/S Ratio
32.29
Revenue / Employee
49.72K
Employees
145
Market Cap
232.80M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.21M857.00K13.49%
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE174.66M
Genfit65.43M
Cellectis65.14M
MedinCell32.44M
Innate Pharma9.01M
Sensorion5.81M
MaaT Pharma4.52M
ABIONYX Pharma4.10M
Revenue Rankings

Transgene News

More News